Article

Dea Belazi, PharmD, Explains the Copay Assistance Program and Its Role in Adherence

Dea Belazi, PharmD, Vice President, Payer & Healthcare Solutions, Source Healthcare Analytics, says a copay assistance program is primarily sponsored or supported by a pharmaceutical manufacturer.

Dea Belazi, PharmD, Vice President, Payer & Healthcare Solutions, Source Healthcare Analytics, says a copay assistance program is primarily sponsored or supported by a pharmaceutical manufacturer. It is intended to provide financial assistance to those patients who require a particular brand of product made by the manufacturer. In improving adherence, a more affordable option helps patients pay for their required drugs.

“If a patient is suffering or is challenged by financial issues with costs in a particular branded product made a manufacturer, “ said Dr Belazi, “the idea is the copay program can support that and therefore make it more financially viable or affordable for the patient to get the product.”

Related Videos
Crystal S. Denlinger, MD, FACP, CEO of the National Comprehensive Cancer Network
Tiara Green, MSEd
Ryan Jacobs, MD, Atrium Health Levine Cancer Institute
Rachel Dalthorp, MD
Quint and Petris
Andrew Cournoyer
Rebecca Flynn, Peter Lio, Timothy Caulfield, and Nichole Halliburton at SPD 2024
Related Content
CH LogoCenter for Biosimilars Logo